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RNA binding motif protein 5 (RBM5) is a candidate tumor suppressor gene. Recent studies showed
that RBM5 functions as an alternative splicing regulator of apoptosis-related genes. Here, we iden-
tify DHX15 and PRP19, two spliceosome components, as novel RBM5-interacting partners. We then
show that the G-patch domain of RBM5 is indispensable for its ability to interact with DHX15. Strik-
ingly, we ﬁnd that RBM5 stimulates the helicase activity of DHX15 in a G patch domain-dependent
manner in vitro. Helicase activities play critical roles in modulating pre-mRNA splicing. Our ﬁndings
thus suggest a new mechanism underlying the regulatory roles of RBM5 in pre-mRNA splicing.
Structured summary of protein interactions:
DHX15 physically interacts with RBM5 by anti tag coimmunoprecipitation (View Interaction: 1, 2, 3, 4, 5,
6, 7).
RBM5 binds to PRP19 by pull down (View Interaction: 1, 2)
RBM5 binds to DHX15 by pull down (View Interaction: 1, 2)
DHX15 physically interacts with RBM5 by two hybrid (View interaction)
PRP19 physically interacts with RBM5 by anti tag coimmunoprecipitation (View Interaction: 1, 2)
RBM5 binds to U2AF65 by pull down (View interaction)
RBM5 physically interacts with DHX15, PRP19, PRPF8 and SNRNP200 by anti tag coimmunoprecipita-
tion (View interaction)
RBM5 physically interacts with DHX15, PRP19 and U2AF65 by anti bait coimmunoprecipitation (View
interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction cell cycle [8]. In 2008, two groups independently reported thatFrequent deletions at chromosomal region 3p21.3 occur in early
stage of lung cancer development, and in breast and renal carcino-
mas [1,2]. RBM5 is one of the nineteen genes located within the
370-kb homozygous deletion region within 3p21.3 [3]. It has been
reported that the elevated expression of RBM5 promotes apoptosis
in cultured cells [4], whereas down-regulation of RBM5 occurs in
RAS-transformed cells [5] and in various human neoplasms [6,7].
Therefore, RBM5 has long been proposed as a candidate tumor
suppressor located at cytoband 3p21.3.
RBM5 has been found to play vital roles in modulating expres-
sion proﬁles of many genes involved in the control of apoptosis andchemical Societies. Published by E
te of Biological Sciences, 7
, Beijing 102206, China. Fax:RBM5 regulates alternative splicing of several genes involved in
apoptosis [9,10]. Although both reports proposed that RBM5 func-
tions in the control of splice site pairing [9,10], and one group
suggested that RBM5 regulates splicing via directly binding to
pre-mRNA [10], the underlying mechanisms have remained largely
unclear. It has been documented that the Octamer Repeat (OCRE)
domain of RBM5 interacts with two components of the U5 snRNP:
U5 200K and U5 220K (PRP8), and is indispensable for the function
of RBM5 in splice site selection [9]. However, it is of note that
RBM5 contains other identiﬁable domains involved in mRNA
metabolism, including the arginine/serine-rich (RS) domain, the
zinc ﬁnger domain, and the glycine-rich domain (G patch domain)
[9]. Here, we demonstrate that RBM5 directly interacts with DEAH-
box polypeptide 15 (DHX15), a DExD/H-box protein that has been
identiﬁed in spliceosome [11], through its carboxyl (C)-terminal
G-patch domain and stimulates the helicase activity of DHX15.
DExD/H-box proteins account for modulating a dynamic network
of RNA-RNA and RNA–protein interactions during pre-mRNAlsevier B.V. All rights reserved.
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involved in splicing regulation.2. Materials and methods
2.1. Cell culture and transfection
HeLa and HEK293T cells were maintained in Dulbecco’s modi-
ﬁed Eagle medium supplemented with 10% fetal bovine serum at
37 C. Sf21 insect cells were cultured in Sf-900 II SFM (GIBCO) at
27 C. Transfectionwas performed using Lipofectamine 2000 (Invit-
rogen). To generate a HeLa cell line stably expressing the Flag-RBM5
fusion protein, we cloned RBM5 cDNA into vector pcDNA3-Flag. The
stable clones were selected by being cultured in the presence of
1 mg/ml G418 (GIBCO). One of the clones was named HeLa-RBM5.
2.2. Co-immunoprecipitation
Co-immunoprecipitation was performed as described [13].
RBM5 is a RNA binding protein. To exclude the effect of contami-
nating RNA attached to RBM5, 50 lg/ml of RNase A (Sigma) was
included in all IP systems. For certain experiments (as indicated
in the text), both 25 U/ml of DNase I (Roche) and 50 lg/ml of RNase
A were added. Bound proteins were analyzed by western blotting
or mass spectrometry (Thermo Electron; Applied Biosystems/
MDS Sciex). Peptide ion identiﬁcations were ranked by Mascot
(Matrix Science). Antibodies were purchased from Sigma–Aldrich
(anti-RBM5 and anti-ﬂag M2); Covance (anti-HA); Santa Cruz
(anti-LUCA15 and anti-PRP19) and ProteinTech (anti-DHX15).
2.3. Puriﬁcation of recombinant proteins
For expression of recombinant RBM5 in Escherichia coli, cells
were grown in the presence of 0.05 mM IPTG for 24 h at 10 C.
The BAC-TO-BAC™ Baculovirus System (Invitrogen) was employed
to express recombinant proteins in insect Sf21 cells. Recombinant
proteins were puriﬁed as described [10].
2.4. In vitro translation and GST pull down assay
35S-labeled proteins were produced by using TNT T7 Quick
Coupled Transcription/Translation System (Promega), and sub-
jected to an incubation with 25 U/ml of DNase I and 50 lg/ml of
RNase A at 25 C for 30 min prior to subsequent analysis. GST or
GST-tagged proteins were mixed with in vitro-translated proteins
or with recombinant proteins, and incubated at 4 C for 2 h. Gluta-
thione Sepharose 4B beads were then added to the mixtures. After
an overnight incubation, the beads were washed three times with
binding buffer. Bound proteins were eluted by boiling in 2
Laemmli sample buffer for 5 min.
2.5. Yeast two-hybrid assays
Yeast two-hybrid assays were performed as described [14]. The
full-length human RBM5 and its derivative were cloned into the
prey vector pGADT7 (Clontech), whereas the human DHX15 cDNA
was inserted into the bait vector pGBKT7 (Clontech).
2.6. Unwinding assays
The 30/50-tailed RNA-DNA substrate was prepared as previously
described with somemodiﬁcations [15]. A 122-nucleotide (nt) RNA
strand (50-GGGCGAAUUGGAGCAGUAAAAAUAAUCUUCAAAAAAAA
AAAAAGGAAAAAAAGGCGGGGAUAUGGGGGUAGAAGACAGUUCAG
GUUCCAAAUCGAGGGGAAAGAAGCCUCCACCGCGGUGGC-30) wassynthesized by in vitro transcription, and was annealed to the 50
32P-labeled DNA oligonucleotides (50-TCTTCTACCCCCATATCCCC-
30) to generate a 30/50-tailed 20 bp RNA–DNA duplex. Unwinding
assays were performed in the presence of 250 nM excessive unla-
beled antisense DNA oligo.
ATPase activity assay was carried out with EnzChek Phosphate
Assay Kit (Invitrogen) according to the manufacturer’s protocol.
3. Results
3.1. Afﬁnity puriﬁcation of human RBM5-associated nuclear complexes
To identify the nuclear binding partners for human RBM5, we
used a ﬂag-tag based afﬁnity puriﬁcation strategy to purify RBM5-
associated complexes from a derivative of HeLa cell, HeLa-RBM5,
which stably expresses ﬂag-tagged RBM5 (ﬂag-RBM5; Fig. 1A). Four
major polypeptides were speciﬁcally co-puriﬁed with ﬂag-RBM5
from the nuclear extract of HeLa-RBM5 cells, but not from parental
HeLa cells (Fig. 1B). MALDI-TOF mass spectrometry analysis was
employed to identify the co-puriﬁed polypeptides. In addition to
U5 220K and U5 200K, two RBM5-associated proteins identiﬁed in
previous studies [9], we identiﬁed two additional spliceosomal
components: DHX15 (95 kDa) and PRP19 (55 kDa), as novel po-
tential nuclear partners of RBM5 (Fig. 1C).
To conﬁrm the interaction between RBM5 and these two asso-
ciated proteins, we next carried out a reciprocal co-immunoprecip-
itation (co-IP) experiment to determine whether endogenous
RBM5 could be co-IPed by anti-ﬂag antibody from whole cell ex-
tracts of HEK293T cells expressing the ﬂag-tagged DHX15 or
PRP19 proteins. Our results showed that RBM5 could be co-IPed
from both extracts by anti-ﬂag antibody (Fig. 1D).
We next utilized antibodies targeting endogenous RBM5 to
determine whether the above observed interactions also occur
among endogenous proteins. Signiﬁcantly, both DHX15 and
PRP19, as well as U2AF65 that is a previously identiﬁed nuclear
binding partner of RBM5 [9], were detected in the immune pellets
from the a-RBM5 antibody, but not in that from the control a-HA
antibody (Fig. 1E). These results indicate that interactions among
RBM5, DHX15 and PRP19 are not artiﬁcially related to exogenously
overexpressed ﬂag-epitope-tagged proteins.
3.2. RBM5 directly interacts with DHX15 and PRP19
To determine whether RBM5 directly interacts with DHX15 and
PRP19, immobilized GST-RBM5 was utilized to pull down 35
S-labeled in vitro-translated PRP19 and DHX15 in vitro. Our data
showed that both DHX15 and PRP19 bound to GST-RBM5
(Fig. 2A). Signiﬁcantly, these interactions were speciﬁc as
GST-RBM5 did pull down in vitro-translated nuclear partner
U2AF65, but not unrelated ﬁreﬂy luciferase (Luc) protein (Fig. 2A,
left panel, lane 5).
To determine whether the observed interactions between RBM5
and in vitro-translated proteins require additional factors pre-
sented in the reticulocyte lysates, GST pull-down experiments
were repeated with recombinant proteins. Our data showed that
both recombinant PRP19 and DHX15 bound to immobilized GST-
RBM5, but not to GST alone (Fig. 2B). Together, these results indi-
cate that RBM5 directly interacts with PRP19 and DHX15 in vitro.
3.3. The C-terminal G patch domain of RBM5 is essential for its
interaction with DHX15
Prp19 is an essential pre-mRNA splicing factor, appearing as an
important component of the NineTeen Complex (NTC) in spliceo-
some [16], whereas relative little is known about the biological
function of DHX15 although its yeast homolog Prp43 has been
Fig. 1. RBM5 interacts with DHX15 and PRP19 in human cells. (A) The expression levels of RBM5 in HeLa and HeLa-RBM5. (B) Silver staining of anti-ﬂag antibody
immunoprecipitated proteins with ﬂag-RBM5 from HeLa (lane 1) and HeLa-RBM5 (lane 2) nuclear extracts. (C) RBM5-interacting proteins identiﬁed by mass spectrometry.
The MASCOT score and number of matching peptides for each protein are shown. (D) Flag-antibody co-immunoprecipitated endogenous RBM5 with ﬂag-epitope-tagged
DHX15 and PRP19. HEK293T cells were transiently transfected with ﬂag-tagged DHX15 and PRP19 expression constructs, respectively. Cell lysates were immunoprecipitated
with anti-ﬂag antibody in the presence of RNase A. Bound proteins were immunoblotted with the indicated antibodies. (E) Anti-RBM5 antibody (a-RBM5) co-
immunoprecipitated DHX15 and PRP19 with endogenous RBM5 from HeLa nuclear extracts with (+) or without () DNase I and RNase A treatment.
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excised lariat-intron from the spliceosome [15]. We therefore focus
on characterization of the interaction between RBM5 and DHX15,
and the putative biological signiﬁcance of this interaction in the
rest of this study.
We ﬁrst aimed to identify the region(s) of RBM5 required for its
speciﬁc binding to DHX15. To this end, we made several HA-tagged
truncations of RBM5 and tested them in co-IP assays (Fig. 3A). The
results showed that truncations of amino acids 511-815 and
742-815 abolished the co-IP of RBM5 with DHX15 (Fig. 3B, right
panel, lane 3 and 5), while truncation of amino acids 1-511 did
not (Fig. 3B, right panel, lane 4).
The above results suggest that the C-terminus of RBM5 is essen-
tial for its interaction with DHX15. This was further corroborated
by yeast two-hybrid analysis (Fig. 3C). While cells expressingfull-length RBM5 and DHX15 showed a blue color within 2 h in
b-galactosidase color assay (Fig. 3C, left panel, lane 4), colonies
coexpressing the C-terminus truncated RBM5 (RBM5DC) and
DHX15 showed only background blue color for up to 12 h
(Fig. 3C, right panel, lane 8), indicating that the C-terminus of
RBM5 is essential for its interaction with DHX15 in yeast two-
hybrid assay. Consistent with this, while recombinant DHX15
bound to immobilized GST-RBM5, it could not bind to
GST-RBM5DC (Fig. 3D).
The C-terminus of RBM5 contains a G-patch domain, which has
been proposed as protein–RNA interaction motif in several RNA-/
DNA-binding proteins [17,18]. To determine the involvement of
G-patch domain in the interaction between RBM5 and DHX15,
we introduced point mutations at the conserved glycine (G)
residues (G to A) within this domain, and monitored the effects
Fig. 2. RBM5 interacts with DHX15 and PRP19 in vitro. (A) Interaction of recombinant GST-RBM5 with in vitro-translated PRP19 and DHX15. Luciferase (Luc), U2AF65, PRP19
and DHX15 were in vitro translated in rabbit reticulocyte lysates with 35S-methionine. Amounts of GST-RBM5 used were monitored by SDS–PAGE followed by Coomassie
blue staining. A representative photograph of the autoradiograph is shown in the left panel. Luc and U2AF65 served as the negative and positive controls, respectively. Right
panel: In vitro translated proteins were subjected to a 30-min incubation with 25 U/ml of DNase I and 50 lg/ml of RNase A at 25 C. Efﬁciency of nuclease treatment was
determined by agarose gel electrophoresis. (B) Recombinant GST-RBM5 protein, expressed in E. coli (E) or insect cells (Sf21), was incubated together with recombinant his-
PRP19 or his-DHX15 in the presence of RNase A and DNase I, and was precipitated on Glutathione-Sepharose 4B beads. Input (left panel) and precipitates (right panel) were
analyzed by SDS–PAGE followed by Coomassie blue staining. GST served as the negative control.
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any single point mutations (data not shown), all tested double or
multiple mutations at the conserved G residues signiﬁcantly
reduced the ability of RBM5 to interact with DHX15, albeit to
different extents (Fig. 3E, lower panel). Importantly, these mutants
did not disrupt the interactions between RBM5 and PRP19 (Fig. S1).
We therefore conclude that the conserved G residues within the G
patch domain of RBM5 are essential and speciﬁc for its efﬁcient
interaction with DHX15.
We also attempted to map the region (s) of DHX15 that are
responsible for its interaction with RBM5 (Fig. S2A). The results
showed that none of the tested truncation was able to interact with
RBM5 (Fig. S2B), suggesting that multiple domains of DHX15 are
involved in its interaction with RBM5.
3.4. RBM5 stimulates the helicase activity of DHX15 in vitro
Since two G patch domain-containing proteins, Ntr1 and Pfa1,
have the capacity to stimulate the helicase activity of Prp43 in
yeast [15,19], we asked whether DHX15 has a similar helicase
activity and whether this activity can be inﬂuenced by its interac-
tion with RBM5. Our data showed that, analogous to its yeasthomolog Prp43, DHX15 has an ATP-dependent helicase activity
in vitro (Fig. 4C). Strikingly, RBM5 signiﬁcantly stimulated the heli-
case activity of DHX15 in a dose-dependent manner (Fig. 4D).
We next want to determine whether the stimulation of RBM5
on the helicase activity of DHX15 is dependent on its interaction
with DHX15. To this end, we puriﬁed a recombinant RBM5 protein
carrying a double mutation m3 + 4 that markedly reduced its inter-
action with DHX15 in vivo. Our result showed that the ability of
this mutant to stimulate the helicase activity of DHX15 was signif-
icantly decreased as compared to that of the wild type (WT) RBM5
(Fig. 4E, left panel, lane 6 and 7). Consistent with this, RMB5, but
not the mutant, sharply increased the ATPase activity of DHX15
in vitro (Fig. S3). These results indicate that RBM5 can act as an
accessory factor to stimulate the helicase activity of DHX15 in a
manner dependent on its C-terminal G-patch domain.
4. Discussion
RBM5 is a putative RNA-binding protein containing twoRNA rec-
ognition motifs, and has been found to function in splicing regula-
tion both in vertebrates and plant [9,10,20]. In this study, we
identify two splicing factors, DHX15 and PRP19, as novel nuclear
Fig. 3. The C-terminal G patch domain of RBM5 is indispensable for its interaction with DHX15. (A) Schematic diagram of the structure of RBM5 and its truncations. 1-511:
from N terminus to the end of OCRE domain; 512-742: from the end of OCRE domain to the beginning of G patch domain; 742-815: from G patch domain to C terminus. (B)
Co-immunoprecipitation experiments were performed using whole cell extracts from HEK293T cells co-transfected with constructs expressing ﬂag-tagged DHX15 and HA-
tagged RBM5. Co-immunoprecipitated proteins were immunoblotted with the indicated antibodies. (C) Determination of interactions between RBM5 truncations and DHX15
by yeast two-hybrid assay. BD, binding domain; AD, activation domain. (D) The C-terminus of RBM5 is necessary for its interaction with DHX15 as demonstrated by GST pull-
down assay. GST pull-down assay was carried out as in Fig. 2B. (E) The conserved G residues within the G patch domain of RBM5 are critical for its interaction with DHX15.
Upper panel: sequence alignment of human G patch domains, generated by Jalview (jalview.org). The conserved G residues are indicated with arrowheads. Lower panel:
HEK293T cells were co-transfected with constructs expressing ﬂag-tagged DHX15 and HA-tagged wild type (WT) RBM5 or its mutants: double mutants (m1 + 2, m3 + 4 and
m5 + 6); quadruple mutant (m3-6); all-G mutant (m1-6). Cell lysates were immunoprecipitated with anti-HA antibody and immunoblotted with the indicated antibodies. The
Co-IP efﬁciency of Flag-DHX15 was normalized by the IP-efﬁciency of the HA-tagged RBM5 mutants.
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domain of RBM5 is indispensable for its interaction with DHX15,
and this interaction is critical for RBM5 to stimulate the helicase
activity of DHX15 in vitro. DExD/H-box RNA helicases play
important roles in multiple steps of pre-mRNA splicing [12]. Our
data therefore provide additional information on our understanding
of how RBM5 acts as a regulator in modulating pre-mRNA splicing.
Two G-patch domain proteins, Ntr1 and Pfa1, have been
reported to stimulate the helicase activities of Prp43 during the
release of lariat-intron from the spliceosome and ribosome biogen-esis in Saccharomyces cerevisiae [15,19]. Here we show that an
alternative splicing regulator RBM5 can stimulate the helicase
activity of DHX15, a functional homolog of Prp43 in human cells,
and the conserved G residues in the G-patch domain are vital for
this effect. However, while DHX15 distributes both in nuclear
speckles and in the nucleoli [11], the nuclear localization of
RBM5 is essentially aside from the nucleolus [9]. It thus seems
unlikely that RBM5 inﬂuences the function of DHX15 in the syn-
thesis of ribosomal RNPs. It also seems unlikely that the association
between RBM5 and DHX15 involves in spliceosome disassembly.
Fig. 4. RBM5 stimulates DHX15 helicase activity in vitro. (A) Schematic diagram of the 30/50-tailed RNA–DNA substrate. (B) Coomassie blue staining of puriﬁed recombinant
proteins used in unwinding assays. BSA: Bovine Serum Albumin. (C) DHX15 has an ATP-dependent helicase activity in vitro. 30/50-tailed substrate (1 nM) and DHX15
(5 nM) were incubated at 30 C in the presence or absence of 1 mM ATP for the indicated times, and analyzed by native PAGE. A reaction that was heated for 3 min at 95 C
before loading was used as a negative control (lane 1). (D) RBM5 stimulates the helicase activity of DHX15 in a dose-dependent manner. Unwinding assay was performed in
the presence of excessive unlabeled antisence DNA oligo, the indicated amounts of RBM5 and 1 lM ATP. (E) The conserved G residues are critical for the stimulatory effect of
RBM5 on the helicase activity of DHX15. Unwinding assay was performed as described in (D); Representative photographs of the corresponding autoradiographs are shown in
left panels. Positions of duplex substrate (ds) and single-stranded product of unwinding (ss) are indicated. Quantiﬁcations are graphically shown in right panels. The relative
value of 32P-label in the single-stranded species was determined as a percentage of duplex and single-stranded species in each lane. Error bars represent standard deviation
from at least three independent experiments. ⁄P < 0.05; ⁄⁄P < 0.01.
982 Z. Niu et al. / FEBS Letters 586 (2012) 977–983RBM5 mainly occurs in prespliceosomal complexes (A complex),
but has not been detected in the spliceosomal complex (B com-
plex) and in lariat-intron complexes [21,22]. This suggests that
RBM5 functions in splicing most likely prior to the appearance of
the B complex. Consistent with this, DHX15 has been identiﬁedas a component of the U2 snRNP, and been detected in both A
and B complex [23,24]. Since DExD/H-box helicase activities are
critical for spliceosome remodeling during each splicing cycle, we
propose that the interaction between RBM5 and DHX15 plays a
role in the maturation of spliceosome, suggestive of a novel
Z. Niu et al. / FEBS Letters 586 (2012) 977–983 983mechanism underlying the regulatory role of RBM5 in pre-mRNA
splicing. While further studies are needed to test this possibility,
it is noteworthy that Silverman et al. has shown that the interac-
tion between a G-patch splicing factor Spp2 and a DExD/H-box
helicase Prp2 is indeed required for spliceosome assembly in yeast
[25].
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